Mitoxantrone Terminated Phase 2 Trials for Mantle Cell Lymphoma (MCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00183989Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma